Onsdag 16 Juli | 09:28:10 Europe / Stockholm

Prenumeration

2025-07-08 16:45:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 6 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)Q2 2025E
Net sales224
Organic growth in local currency (%)11.60
Gross profit166
EBITDA46.5
EBIT28.7
Net profit17.8
Earnings per share (SEK)0.55

XVIVO Perfusion’s Q2 report will be released on Friday, 11 July 2025 at 07.30 CEST.